Washington University School of Medicine in St. Louis

The Program in Psychedelic Research (PiPer) is a partnership between The Healthy Mind Lab, the Washington University Neuroimaging Lab, and Usona Institute. PiPer leverages 30 years of neuroimaging research and four decades of psychiatry research. The group has started with four research projects around neuroimaging data in humans and animals. The university also serves as a site for Usona's Phase II/III trial with 25mg of psilocybin.